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Cancer chemotherapy is associated with serious side ef-
fects, including temporary hair loss and impairment of 
pigmentation. We suspect that ectopic melanin deposi-
tion occurring due to chemotherapy may add to these 
effects worsening the already unpleasant symptoms. We 
associated the ectopic occurrence of follicular melanin af-
ter chemotherapy with splenic melanosis — an interest-
ing example of extradermal melanin localization — and 
we expected an increase in splenic melanin deposition 
after chemotherapy. Using the C57BL/6 murine model of 
synchronized hair cycle induced by depilation, we visu-
alized splenic melanin by means of several histological 
and histochemical protocols of staining: hematoxylin and 
eosin, May-Grünwald-Giemsa and Fontana-Masson. Un-
expectedly, the splenic deposition of melanin decreased 
due to application of cyclophosphamide (i.p. 120 mg/ 
kg body weight on day 9 post depilation). The drop was 
abrupt and lasted for at least 5 days (day 13–18 post de-
pilation), as compared with normal hair cycle. Moreover, 
in mice with normal, depilation-induced hair cycle we 
observed a similar drop shortly before entering catagen 
(day 15 post depilation), followed by a slow and partial 
increase in splenic melanization up to day 27 post depila-
tion in both groups. We conclude that cyclophosphamide 
negatively affects splenic melanization and/or extrader-
mal transfer of ectopic melanin from the dystrophic hair 
follicles, but the most powerful down-regulator of splenic 
melanosis is normal and dystrophic catagen — the phase 
of hair follicle involution and re-modelling.
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INTRODUCTION
One of the most acute side effects of cancer chem-
otherapy is hair loss and impairment of hair pigmen-
tation. This phenomenon adds to the overall depres-
sive condition of patients making them feel devastated 
and is sometimes a reason for giving up chemotherapy 
(McGarvey et al., 2001). Understanding the underlying 
mechanisms is, consequently, an important factor of the 
success in cancer therapy. One of the related problems 
is the fate of epidermal and follicular melanin which is 
initially deposited ectopically in response to chemother-
apy (Braun-Falco, 1961). This melanin is toxic in itself 
(Slominski et al., 1996; Swartz et al., 2005; Wood et al., 
2009) and affects the general condition of the organism. 
Moreover, the pigmented tumors (melanotic melanoma) 
may also reveal symptoms of deregulated melanogenesis, 
which may influence the process of therapy (Plonka et 
al., 2003; Lazova et al., 2010). This makes the topic of 
extradermal melanin transfer important also from the 
oncological point of view (Michalczyk et al., 2009).
Melanin, an amorphous polymer responsible for skin 
and hair pigmentation, may be also found in other or-
gans. In higher vertebrates, including humans (Wasser-
man, 1967), melanin has been reported, besides skin, in 
visceral organs, and its presence and origin in such ex-
tradermal locations is enigmatic. Pigmentation of murine 
spleens was noted for the first time by Weissman (1967). 
Early studies delivered numerous hypotheses concern-
ing the identity of the pigment. In (1978) Crichton et al. 
identified the pigment as lipofuscin. In (1989) Veninga et 
al. postulated deposition of hemosiderin as the cause of 
spleen pigmentation. Work of Sundberg et al. (1991) and 
van der Heijden et al. (1995) finally confirmed the pres-
ence of melanin. Simultaneously, they excluded lipofuscin 
— the pigment characteristic for ageing, since the phe-
nomenon was observed in young animals. The presence 
of melanin was directly proved by Plonka et al. (2005) 
by means of electron paramagnetic resonance (EPR, also 
called electron spin resonance, ESR). In (2009) Michal-
czyk et al. indicated that partial melanization of spleens 
is observed in young C57BL/6 mice (younger than 10 
weeks) with synchronized hair cycle. Meanwhile, over 
one-year-old mice revealed no splenic melanosis, instead, 
“melanin debris” could be observed in some of these old 
mice.
Excessive melanin deposition (melanosis) of inner or-
gans is a long-studied phenomenon (Wasserman, 1967). 
It has recently turned out that melanophores play an im-
portant part in amphibian metamorphosis, which includes 
total re-building of the tissues, including skin. An inter-
esting manifestation of this process is deposition of mel-
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anin in the liver and other visceral organs of the animals 
(Divya et al., 2010). Understanding the origin and mecha-
nism of splenic melanization in mice is, therefore, im-
portant from the point of view of general biology, evolu-
tion of the skin, and experimental dermatology (Rakers et 
al., 2010). The most important, hypothetical extrasplenic 
source of the murine spleen melanin are the hair follicle 
melanocytes.
The mammalian hair follicle is a mini organ, which 
undergoes continuous remodelling through the whole 
animal life in the process called hair cycle (Chase, 1954; 
Müller-Röver et al., 2001). In many animals, includ-
ing mice, it is synchronized over big areas of skin (Dry, 
1926). The hair grows and gains melanin only in anagen 
— the stage of hair growth. In the subsequent stage — 
catagen (well synchronized in young C57BL/6 mice, and 
followed by telogen, the “resting” stage), follicular mel-
anocytes undergo massive apoptosis, and the melanin-
containing apoptotic bodies are phagocytosed initially by 
the Langerhans cells (Tobin, 1998) and then transferred 
further, probably as far as to the spleen. In the mean-
time melanin undergoes partial degradation (Borovansky 
& Elleder, 2003; Plonka et al., 2005). Therefore, splenic 
melanization must be correlated with the progress of the 
hair cycle.
Impairment of the hair cycle and of the related mela-
nin production is often associated with ectopic deposition 
of the pigment in the hair follicle outside the hair shaft. 
Such pathological melanization is a side-effect of cancer 
chemotherapy with cyclophosphamide (CYP) in humans 
(Braun-Falco, 1961), and in model mice (Kostanecki et 
al., 1967). This is a rationale to suppose that in such a 
case a particular increase in splenic melanin deposition 
can be expected. On the other hand, in normal mice we 
found less splenic melanin in early telogen than in late 
telogen (Plonka et al., 2005) while one of the ways through 
which hair follicles can recover from CYP-related dystro-
phy is to enter dystrophic catagen followed by dystrophic 
telogen (Paus et al., 1994a). It creates the necessity to as-
sess splenic melanosis over the whole hair cycle, in its 
every stage, with and without CYP administration. The 
presence of melanocytes in murine skin is limited al-
most exclusively to hair follicles (Chase, 1954; Slominski 
et al., 2005). Since these laboratory rodents exhibit the 
wave-like type of hair growth (Dry, 1926; Chase, 1954; 
Chase & Eaton, 1959), synchronization of every stage of 
the hair cycle is possible, which is even more prominent 
in the case of the depilation-induced cycle (Paus et al., 
1990). Therefore, this model is of particular suitability to 
study correlation between splenic melanosis and hair cy-
cling.
For microscopic examination of splenic melanosis we 
chose three methods of histological staining often ap-
plied in experimental dermatology: hematoxylin and eosin 
(HE; Paus et al., 1999b; Müller-Röver et al., 2001; Shirai 
et al., 2001; Hendrix et al., 2005), May-Grünwald-Giemsa 
(MGG; Paus et al., 1994b; Müller-Röver et al., 2001; Lu et 
al., 2009), as well as Fontana-Masson (FM; Slominski & 
Paus, 1993; Slominski et al., 1994; 2004; 2005).
One of the most popular and widely applied is hema-
toxylin and eosin staining (Mayer, 1891; 1904). It em-
ploys two dyes specific for different cell compartments. 
Hematoxylin, a blue dye, possesses affinity to basophilic 
(acidic) structures within the cell (mainly chromatin, 
therefore the nucleus is visualized very efficiently). To 
obtain a sharp contrast with the blue hematoxylin sig-
nal, the staining with purple eosin Y is used. This dye 
shows affinity to acidophilic structures (usually positive-
ly charged, because eosin is an acid). In practice, eosin 
stains the entire cytoplasm and cell membrane of various 
types of cells (Romeis, 1991; Avwioro, 2011).
Another staining method whose specificity is based on 
electrostatic interactions between the dye and the target 
structures is May-Grünwald-Giemsa stain (MGG). May- 
Grünwald staining solution is composed of eosin Y and 
methylene blue. Giemsa solution is applied separately and 
is composed of azure-type dyes: azure II is a mixture of 
methylene blue and its derivative in 1 : 1 proportions, and 
of eosin. The Properties of azures and methylene blue 
are similar to those of hematoxylin — these dyes, car-
rying a positive charge, stain nuclei and basophilic cells 
(Barcia, 2007).
The third staining procedure is based on the reduction 
of diamminesilver(I) nitrate to metallic silver(0) under 
the influence of reductive agents present in the cell. This 
method, described by Fontana (1912) and Masson (1914), 
was applied by Fontana for visualization of a spirochete 
(Treponema pallidum), and in its basic version it is known 
as Fontana-Masson (FM) staining. Masson applied ‘silver 
solution’ for visualization of neuronal structures (Moore 
et al., 2001). Cells which reduce diamminesilver(I) nitrate 
to metallic silver(0) are referred to as argentaffins. A pos-
itive result of such ‘silver stain’ is mostly correlated with 
the presence of serotonin (Barter & Pearse, 1955) and 
other biogenic amines such as dopamine or ephedrine 
(Lundqvist et al., 1990). Melanins are composed mainly 
of derivatives of dihydroxyindole monomers that can be 
oxidized by diamminesilver(I) nitrate and thus melanins 
can be marked with metallic silver(0) (reaction 1).
Reaction 1. Schematic illustration of the principle of silver(I)-de-
pendent oxidation of melanin.
EPR spectroscopy is widely used to investigate mel-
anin-containing tissues. Paramagnetic properties of this 
pigment were pointed out for the first time in 1954 
(Commoner et al., 1954). Since then EPR has been ap-
plied to quantitative (Pilas & Sarna, 1985; Slominski et al., 
1994), and qualitative (Sealy et al., 1982) assays of mela-
nin and of its microenvironment in the tissue (Felix et al., 
1978; Plonka et al., 2005). It is, however, not able to lo-
calize melanin spatially in the spleen tissue. Instead one is 
bound to use standard histological methods.
In the present paper we compared HE and MGG 
staining and the FM method, which is melanin-specific 
in terms of quality and potential to visualize melanin 
and the contours of individual cells, in murine C57BL/6 
spleens. The presence of melanin was verified indepen-
dently by means of EPR spectroscopy. We checked the 
presence of splenic melanosis on subsequent days after 
induction of the hair cycle by depilation. We also exam-
ined whether chemotherapy with CYP increases or de-
creases splenic pigmentation, and discussed what implica-
tions it may have for cancer treatment.
MATERIALS AND METHODS
Instruments. Paraffin slices were prepared using a 
manual Finesse 325 microtome (Thermo Shandon, Run-
corn, UK), images of stained tissues were taken by a re-
versed Eclipse Ti microscope (Nikon Corporation, Tokyo, 
Japan) equipped with the Nis elements F 3.0 imaging soft-
ware (Nikon Corporation, Tokyo, Japan), and an analog 
camera (PENTAX ME, Asahi Opt. Co., Tokyo, Japan) 
equipped with 1:4.5/8–20 mm Soligor MC lenses (Sun 
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Optical Co., Ltd., Ichikawa, Japan) adjusted for mac-
rophotography. EPR spectra were recorded by an E-3 
spectrometer (Varian, Sunnyvale, LA, USA) in a Wil-
mad finger quartz Dewar WG-816-B-Q (Rototec-Spintec 
GmbH, Griesheim, Germany). Animals were shaved with 
an animal shaver (Braun AG, Kronberg, Germany).
Reagents. Giemsa, May-Grünwald, ethyl eosin and 
1,1-diphenyl-2-picrylhydrazyl (DPPH) were purchased 
from Sigma-Aldrich Corporation, (St. Louis, MO, USA), 
Mayer hematoxylin from Aqua-Med (Łódź, Poland), sil-
ver nitrate, methyl red, sodium thiosulfate, methyl sa-
licylate, sodium thiosulfate, ethanol, formaldehyde and 
xylene from POCh (Gliwice, Poland), ammonia from 
Eurochem Service Poland Sp. z o.o. (Warszawa, Poland), 
Sedazin® from Biowet Puławy Sp. z o.o. (Puławy, Po-
land), ketamine (Ketanest 50®) from Parke-Davis GmbH 
(Berlin, Germany), cyclophosphamide (CYP; Endoxan®) 
from ASTA Medica AG (Frankfurt, Germany), saline 
from Polpharma SA (Stargard Gdański, Poland), paraffin 
from Thermo Shandon (Runcorn, UK), beeswax from 
Aldrich Chemical Co. (USA), and gum rosin from Sigma 
Chemical Co. (USA). For histology, Polysine® slides and 
Consult Mount (mounting medium) were obtained from 
Thermo Shandon, (Pittsburgh, USA), and cover glasses 
(Citoglas®, China) from ElektroMed (Niepołomice, Po-
land).
Biological material. The biological material was col-
lected over a long time and during several different ex-
periments, all of which were approved by the 1st Local 
Committee for Animal Research in Kraków (221/95, 
303/97, 15/OP/2004). Female, 6–8-week-old C57BL/6 
mice (Animal Breeding Facility, Silesian Medical Acad-
emy, Katowice-Ligota, Poland) were selected for depila-
tion based on the pink color of their back skin (all hair 
follicles in telogen, Paus et al., 1990). Depilation was ex-
ecuted in ketamine anesthesia by application of melted 
1:1 mixture of beeswax and gum rosin and peeling out 
the hair coat after hardening, according to Paus et al., 
(1990). On day 9 post depilation (p.d.) the CYP-treated 
animals were administered a single i.p. dose (120 mg/kg 
body weight) in a small volume (ca. 0.1–0.2 ml) of sa-
line (Paus et al., 1994a; Hendrix et al., 2005), while the 
control animals were given vehicle. At subsequent time 
points (see Fig. 1) the animals were shaved if necessary, 
photographed, and killed by cervical dislocation in deep 
ketamine anesthesia, whereupon the skin was separated 
at the level of subcutis, spread on a piece of cardboard, 
and fixed in buffered 5% formalin (phosphate buffer, 
pH = 7.4). We determined the stage of the hair cycle and 
dystrophy of the hair follicles based on the tabularized 
criteria of histomorphometry (Müller-Röver et al., 2001; 
Hendrix et al., 2005).
The spleens of animals were carefully examined on 
necropsy for macroscopic evidence of melanosis and 
fixed in the formalin solution for histology. We estimat-
ed the area of melanosis and calculated the percentage 
of melanotic spleens per a given experimental group of 
mice. A part of spleens was frozen in liquid nitrogen for 
EPR measurement.
Preparation of tissue slices for histology. To pre-
pare paraffin blocks, the spleens, after a long fixation in 
formalin, were rinsed with water (24 h), dehydrated in 
the series of aqueous solutions with increasing concentra-
tion of ethanol (50%–1 h, 70%–2 h, 80%–2 h, 96%–12 h, 
100%–40 min, 100%–1 h) and then in methyl salicylate 
(4 h), xylene (10 min) (all at room temperature) and 
embedded in paraffin blocks. Shortly before cutting into 
5 μm slices the paraffin blocks with embedded spleens 
were additionally cooled in icy water. We found it an im-
portant step preventing the spleen tissue from crumbling.
The middle-dorsal pieces of skin were flushed with 
water (24 h), dehydrated in a series of ethanol solu-
tions (50%–1.5 h, 70%–1.5 h, 80%–1.5 h, 96%–12 h, 
2 × 100%–30 min), immersed in anhydrous ethanol and 
xylene (1  : 1, v : v) (2 × 30 min) and xylene (30 min) (all at 
room temperature), embedded in paraffin blocks, and cut 
in 8 μm slices.
Pre-treatment of slides with tissue sections. Par-
affin sections of spleen tissues on Polysine® slides were 
deparaffinized by: a) incubation of the slides in 56°C for 
20 min to melt paraffin and to attach the tissue to the 
surface of glass, b) dissolution of the melted paraffin in 
xylene (5 min) and then immersing the slides in fresh 
xylene several times, and c) re-hydration of the tissue by 
immersing the slides in a series of aqueous solutions with 
decreasing concentration of ethanol (100, 96, 80, 70, 50, 
0% of ethanol, v/v, respectively).
Hematoxylin and eosin (HE) staining. The depar-
affinized slices were incubated in hematoxylin working 
solution (12 min) at room temperature, flushed with tap 
water (15 min), counterstained for 1.5 min in 0.1% etha-
nol solution of eosin acetified with a few drops of acetic 
acid, dehydrated in the ethanol se-
ries (70%, 2 × 96%, 2 × 100%, v/v, 
respectively), 2 × xylene (all at room 
temperature), sealed in balsam and 
covered (Romeis, 1991).
May-Grünwald-Giemsa (MGG) 
staining. Working solution of 
Giemsa was prepared by mixing 0.5 
ml of concentrated Giemsa stock 
solution with 200 ml of distilled 
water. The MG working solution 
was prepared by mixing 15 ml of 
MG stock solution with 160 ml of 
distilled water. Deparaffinized slides 
with samples were incubated in MG 
working solution for 20 min at 37°C 
in a Coplin jar covered with alumin-
ium foil to protect against light. The 
samples were then introduced into 
Giemsa working solution for 40 min 
at 37°C, immersed quickly in 0.15% 
solution of acetic acid to obtain neu-
tral pH, washed in distilled water, 
Figure 1. Experimental design. 
Empty circles, harvesting of spleens; black circles, harvesting of skin. Below, general 
scheme of normal hair cycle in C57BL/6 mice, and dystrophic hair cycle after administra-
tion of cyclophosphamide (i.p. 120 mg/kg body weight) on day 9 post depilation (accord-
ing to Müller-Röver et al., 2001, and Hendrix et al., 2005).
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dehydrated, sealed in balsam and covered with glass cov-
erslip like for HE staining (Zawistowski, 1983).
Fontana-Masson (FM) staining for melanin. Due 
to the sensitivity of the applied ammoniacal silver nitrate, 
it was prepared immediately before the staining proce-
dure. Concentrated ammonia was added drop by drop 
to 20 ml of 10% solution of silver nitrate until the white 
precipitate of silver(I) oxide was almost dissolved (hardly 
noticeable opalescence). The obtained solution was dilut-
ed by adding 20 ml of distilled water, then filtered and 
stored at 4°C in a bottle protected from light.
Deparaffinized slides with samples were rinsed in dis-
tilled water and incubated in silver solution for 40 min at 
56°C in a Coplin jar covered with aluminium foil, while 
the control slides were incubated similarly in distilled wa-
ter. After washing in distilled water, the slides were incu-
bated in 5% sodium thiosulphate (3 min), flushed with 
tap water (3 min), counterstained in 0.5% aqueous so-
lution of toluylene red (neutral red) for 5 min to stain 
nuclei, flushed with tap water again, dehydrated by im-
mersion for a few seconds in the ethanol series (70, 96 
and 100%, v/v; × 2 each) and then in xylene (10 min), 
whereupon the slides were conserved with balm and cov-
ered with a glass coverslip (Bancroft & Stevens, 1982).
EPR measurements. Whole amelanotic and melanot-
ic spleens were analyzed in a Dewar quartz tube in liquid 
nitrogen (77 K) at X-band (ca. 9.2 GHz), 4 mW micro-
wave power and 5 Gs modulation amplitude. Amplifica-
tion of the signal was set at 8 × 105 (melanotic spleens) 
or 1.25 × 106 (amelanotic spleens). Each spectrum was 
averaged from 3 scans at 200 s scan time and 0.3 s time 
constant.
Statistical evaluation of the data. We examined 1–5 
experimental groups, each of 2–8 animals, per time point 
(5–22 animals per time point). We expressed the aver-
age melanotic area of a spleen (% of the total area) as 
the mean of the pooled data for a time point ± S.E. We 
also calculated the total percentage of spleens revealing 
melanosis per time point (i.e. pooled groups examined at 
a given time point). Altogether we examined 161spleens 
(92 control and 69 CYP-treated). The two-tailed inde-
pendent Student’s t-test was used to evaluate the statis-
tical significance of the differences between the means, 
and the Snedecor F test to assess the significance of the 
differences in variances. The differences were accepted as 
significant for p < 0.05.
RESULTS AND DISCUSSION
Visualisation of splenic melanin
Splenic melanosis manifests itself macroscopically 
(Fig. 2A–D) and has been described in C57BL mice as 
“black spots” (Weissman, 1967). It is a “yes-or-no” 
phenomenon, and for yet unknown reasons in all inves-
tigated groups there are animals with either melanotic, 
or non-melanotic spleens. As a result, in a given animal 
the existence of splenic melanosis cannot be determined 
without laparotomy (Weissman, 1967; van der Heijden et 
Figure 2. Macroscopic (A–D) and microscopic (E–P) manifestation of splenic melanosis in C57BL/6 mice. 
Black spots in normal (B); and cyclophosphamide-treated (D; i.p. 120 mg/kg body weight, on day 9 p.d.) spleens and amelanotic spleens 
(A, C, respectively). E–P, corresponding histological examinations of spleens from pictures A–D (respectively). E–H, hematoxylin and eosin 
staining; I–L May-Grünwald-Giemsa staining; M–P, Fontana-Masson histochemistry. Arrows, melanin. Untreated amelanotic spleen (A, E, I, 
M) — day 15 p.d., the other pictures — day 13 p.d. Scale bars: A–D, 1 cm; E–P, 100 µm.
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al., 1995; Plonka et al., 2005). On the other hand, as the 
black spot is sharply separated from the amelanotic back-
ground, it is easy to assess melanosis macroscopically as 
the average percentage of the melanotic area of spleens 
and the percentage of mice revealing melanosis in a giv-
en group.
We have shown here that melanin granules can be 
histologically visualized by means of all the applied meth-
ods. As it can be seen in Fig. 2E–P, the depicted melanin 
granules are dyed in a comparable way — the gamut of 
colors ranges from yellow-brown to black. On the basis 
of the properties of the applied chromophore molecules, 
one may attribute the positive result of staining to basic 
dyes (methylene blue and its derivatives) due to the nega-
tive net charge of melanin. However, a touch of yellow 
(e.g. Fig. 2F) suggests a contribution of eosine Y, pos-
sibly thanks to the π-π stacking interaction (similar to 
that present in the aggregates of eumelanin promolecules; 
Meredith & Sarna, 2006).
Metallic silver (Fig. 2M–P) has been shown to be an 
effective marker of melanin granules in Fontana-Masson 
staining (Slominski et al., 1994; 1996; 2004; 2005). How-
ever, to prevent ‘false positive’ results, the time of incu-
bation in the solution of diamminesilver(I) nitrate should 
not be exceeded. According to our observations, a sig-
nificant concentration of melanin may sometimes lead to 
the excessive intensity of silver deposition, and prolonga-
tion of the incubation time may lead to non-specific pre-
cipitation of silver(0), possibly due to other mild reducing 
agents apparently present in cells. Nevertheless, while the 
time of incubation in “silver solution” should always be 
carefully considered, sometimes a slight prolongation or 
even moderate heating of the bath increases the quality 
of the picture. To sum up, a negative control (incubation 
without silver nitrate) is always indispensable.
It should be stressed that neither of the two “non-sil-
ver” methods (HE or MGG), stains melanin specifically. 
Their role is to increase the contrast between the back-
ground and melanin granules. On the contrary, FM stain-
ing is the method which directly, histochemically stains 
melanin and as such, it may be applied to confirm the 
reducing potential of the previously visualized granules.
A perfect, independent method to determine direct-
ly the presence of melanin in a given sample is EPR 
spectroscopy (Sarna & Plonka, 2005). The results of 
EPR assay of the spleens of young mice with the pres-
ence (mel+) and the absence of visible melanization 
(mel-) are shown in Fig. 3. Additionally, an EPR spec-
trum of DPPH was recorded as a free radical standard 
(g = 2.0037 ± 0.0002; Wertz & Bolton, 1984). The shape 
Figure 3. Electron paramagnetic resonance signals of normal 
C57BL/6 murine spleens. 
mel +_01, mel +_02, melanotic spleens (day 15, and day 0 p.d., 
respectively). mel-, amelanotic spleen (day 0 p.d.). DPPH, the free 
radical standard. For parameters of EPR assay see “Material and 
Methods”.
Figure 4. Macroscopic manifestation of hair cycle and cyclophos-
phamide-induced alopecia in C57BL/6 mice. 
(A) female, 7 week-old mice were depilated in telogen (day 0, note 
the pink color of the back skin), and (B) injected i.p. CYP (120 mg/
kg body weight ) on day 9, i.e. at the beginning of anagen VI (note 
the dark-blue color of the skin due to intensive melanogenesis). 
The first symptoms of alopecia were noticeable on day 13 p.d. (D 
— white arrows), and progressed through day 14 (F) up to day 
15 (H), while in control mice the hair follicles produced a normally 
pigmented hair coat (C, E, G — vehicle control, day 13, 14, 15 p.d., 
respectively). Note the deep-blue color of the bald skin on day 15 
p.d. (H). The hair coat of the CYP-treated animals was still recover-
ing on day 27 (J) when the skin still revealed symptoms of dystro-
phy (impaired pigmentation — d) beside regions of skin with hair 
follicles in the 2nd (recovery) anagen (r), while the hair of control 
mice (I) had been for a long time in deep telogen (note the pink 
color of the skin uncovered by shaving).
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of the splenic signal and its position prove that all the 
observed radical centres are isolated and each contains 
only one unpaired electron not coupled with any other 
electron or nuclear spin, therefore confirming the pres-
ence of eumelanin in the spleens (Meredith & Sarna, 
2006).
The mel- signal is distinctly weaker than both the mel+ 
ones, and originates from endogenous free radicals asso-
ciated with mitochondrial respiration (Fig. 3; Slominski 
et al., 1994; Plonka et al., 2003; Elas et al., 2008). Since, 
due to a relatively small amount of melanin in the spleen, 
the melanin-derived signal is rather weak as compared to 
the non-melanin one, the quantitative EPR determination 
of melanin may be charged with a relatively substantial 
experimental error. Moreover, despite direct and unam-
biguous correlation between the presence of melanin 
spots on the tested spleens and the occurrence of the 
EPR signal characteristic of eumelanins, EPR spectros-
copy does not provide resolution on the “cellular” level. 
The recently reported attempts to employ the technique 
of EPR imaging (EPRI; Godechal et al., 2012) did not 
provide a satisfactory resolution. As such, EPR consti-
tutes a complementary approach to histological staining 
protocols which gives an insight into the distribution of 
melanin in the tissue.
Hair cycle and melanogenesis
In the murine trunk skin mature, melanin-producing 
melanocytes are present only in the anagen hair follicles 
(Slominski & Paus, 1993; Slominski et al., 1994). Mac-
roscopically it is manifested by a grey–to–black color 
of the skin (Fig. 4B, C), in contrast to the pink telogen 
skin (Fig. 4A, I), totally devoid of mature (i.e. melanin-
producing) melanocytes (Fig. 5A). The changes of mac-
roscopic skin are particularly well noticeable in the de-
pilated skin (Fig. 4A, B). The active melanogenesis starts 
about day 5 p.d. (anagen III), and lasts to the end of ana-
gen VI (day 15–16 p.d.; Müller-Röver et al., 2001). The 
hair follicle in anagen VI is fully developed and contains 
a strongly melanized hair shaft and a developed popula-
tion of mature, melanin-producing melanocytes (Fig. 5B, 
C).
If a strong alkylating chemotherapeuticum, like CYP, is 
applied on day 9 p.d., i.e. at the beginning of anagen VI 
(Fig. 1, 4B, 5B), the hair follicles react by acute dystro-
phy (Braun-Falco, 1961; Kostanecki et al., 1967; Paus et 
al., 1994a; Slominski et al., 1996). The whole population 
of multiplying melanocytes and keratinocytes undergo 
abrupt apoptosis (Hendrix et al., 2005), resulting in alope-
cia (Fig. 4D, F, H), whereas in the control skin (Fig. 4C, 
E, G) the anagen VI hair follicles still produce normally 
pigmented hair shafts (Fig. 5B, C). As a result, on day 
15 the CYP-treated animals are almost completely devoid 
of hair (Fig. 4H). The color of the skin, however, still 
indicates the presence of melanin. And indeed, ectopic, 
extracellular melanin deposition (Fig. 5D–F) is associated 
with both possible pathways that allow the dystrophic hair 
follicles to recover from the CYP-induced impairment: 
via dystrophic anagen (Fig. 1, 5D), or via dystrophic cat-
agen (Fig. 1, 5E) and telogen (Fig. 1, 5F), each accompa-
nied by a transient hair loss (Paus et al., 1994a; Slominski 
et al., 1996; Hendrix et al., 2005). This may be particularly 
well appreciated in comparison to normal anagen VI hair 
follicles, in the histological pictures with the FM staining 
of melanin (Fig. 5C). Actually, the CYP-induced dystro-
phy may be very strong (Hendrix et al., 2005) and it af-
fects the apparatus of hair follicle melanogenesis, causing 
ectopic (hair root sheaths, sebaceous gland etc.) melanin 
deposition and clumping of the amorphous melanin mass 
in the hair channel (Slominski et al., 1996; Hendrix et al., 
2005; Paus et al., 2013). We suspected this ectopic mela-
nin (Fig. 5D–F) to be the source of the presumptive in-
crease in melanin deposition expected by us to occur in 
the spleen after CYP-induced alopecia.
Splenic melanosis during normal and CYP-impaired hair 
cycle
In Fig. 6 we have shown the summary of our exten-
sive observations of the correlation between splenic mel-
anosis and the progress of hair cycle, at particular time 
points after depilation. The samples were collected over 
a long time and pooled from several independent experi-
ments and from the control groups of other experiments. 
As the splenic melanization is a “yes-or-no” phenom-
enon (Plonka et al., 2005), only such an extensive study 
could deliver any quantitative comparisons.
And indeed, as it can be seen in Fig. 6A, the intensity 
of splenic melanosis changes according to the progress 
Figure 5. Histological manifestation of hair cycle-related mel-
anogenesis and its impairment due to cyclophosphamide in 
C57BL/6 mice. 
(A) a telogen hair follicle without melanocytes on day 0. (B, C) 
normal anagen VI hair follicles with normally pigmented hair shafts 
(blue arrows) on day 9 (B), and 15 p.d. (C). (D, E, F) dystrophic hair 
follicles on day 15 p.d in late dystrophic anagen (white arrows), 
late dystrophic catagen (black arrows) and dystrophic telogen (red 
arrows). The criteria of dystrophy — according to Hendrix et al., 
(2005). The black and white arrows point at both the granules of 
ectopic melanin, and melanin clumping in the hair channel (red 
arrows). This melanin was expected to be scavenged by melano-
phages and transported to the spleen. A, E, F — HE; B, C, D — FM. 
Scale bars, 100 µm.
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of normal hair cycling. The most important observa-
tion concerns the period shortly preceding and following 
the onset of catagen, with a strong drop in the melani-
zation (Fig. 6A, B, day 15). This drop was followed by 
an increase during the subsequent long telogen period, 
confirming our earlier observations (Plonka et al., 2005). 
Catagen, as other stages of the synchronized hair cycle, 
is a phenomenon systemically influencing the murine or-
ganism (Slominski et al., 1997; Paus et al., 1999). Here we 
show its association with a drop in splenic melanosis in 
C57BL/6 mice.
If this is the case, the drop should be observed also 
in the CYP-treated animals, moreover, earlier than in the 
controls. And indeed, we found it happening, as shown 
in Fig. 6 (day 13). The decrease is abrupt and followed 
by a gradual re-storage of melanin in the spleens, up to 
the level of the control (Fig. 6, days 13–27). This can be 
confirmed with macroscopic (Fig. 2C, D), and histologi-
cal examination of the spleens, revealing smaller and few-
er deposits of melanin in the organ using the FM stain-
ing (Fig. 2P) confirmed by the MGG (Fig. 2L), and HE 
(Fig. 2H) visualization.
As chemotherapy with CYP influences strongly the 
follicular melanogenesis, we expected a reverse effect in 
the spleens. We expected scavenging of 
the abundant CYP-induced ectopic mela-
nin mass (Fig. 4D–F) by melanophages, 
and consequently, its massive and de-
layed deposition in the spleen. Mean-
while, we have found poorer melanization 
of CYP-treated than untreated spleens 
for at least 6 days (Fig. 2 D, L, H, P, 6 
day 13–18) and a slow re-melanization of 
the spleens to the level of the control.
The overall picture of the splenic 
melanosis in parallel to the progress of 
normal or CYP-disrupted hair cycle is 
as follows. There are three clear phases 
of the phenomenon. Initially, melanosis 
is quite high, and culminates on day 9. 
Next, it drops down till day 15, i.e. the 
day directly preceding catagen. Finally, 
it increases slowly back on the border 
of statistical significance for the next 12 
days (during telogen). If CYP is adminis-
tered on day 9, the drop is much more 
abrupt, (the minimal value on day 13), 
followed by a 15-day re-pigmentation.
However, on day 18 the CYP-treated 
spleen pigmentation is still significantly 
lower than the control. The CYP-treated 
spleens reveal decreased pigmentation 
longer than the normal ones. It can be 
manifested both macroscopically (Fig. 
2C, D), and histologically (Fig. 2G, H, 
K, L, O, P), as well as supported quanti-
tatively (Fig. 6).
The peak of splenic melanization can 
be observed on day 9, i.e. at the onset 
of anagen VI. As this is also the point 
of the highest activity of the hair-cycle-
associated melanin synthesis (Plonka 
et al., 1995), splenic melanosis could be 
associated with skin melanogenesis, if it 
was not for the presence of splenic mela-
nosis in the absence of melanin synthe-
sis in the telogen skin (from day 18 to 
day 27; see Fig. 4I ). During this time the 
CYP-treated skin is a mosaic of all the 
phases of normal and dystrophic hair cy-
cle (Plonka et al., 2006; see also Fig. 4J). The lowest in-
tensity of splenic melanization is associated with the on-
set of dystrophic anagen and catagen (Fig. 5D–F), which, 
after injection of CYP on day 9, can be observed on day 
12–13, i.e. earlier than in the control animals (Paus et 
al., 1994a; Hendrix et al., 2005). Concluding, our observa-
tions strongly suggest that the primary factor responsible 
for splenic melanosis is the stage of the hair cycle, not 
the content of ortho- or ectopic melanin in the hair fol-
licle. However, since even in the CYP-treated mice, ca. 
one fifth of the spleens (Fig. 6B) revealed weak (Fig. 6A) 
melanosis on day 13 we still cannot explain the reason 
of such a “digital” (“zero-or-one”) manifestation of this 
phenomenon in C57BL/6 mice.
CONCLUSIONS
The results of our experiments lead to important prac-
tical implications. First of all, CYP abruptly and for a consid-
erable period decreases splenic melanosis despite deposition of 
ectopic melanin in the CYP-treated skin. During normal 
catagen melanin is released from the apoptotic melano-
Figure 6. Splenic melanosis at particular time points of depilation induced, normal 
(CTRL) and dystrophic (CYP) hair cycle in C57BL/6 mice. 
(A) average area of melanosis (means ± S.E.M.); (B) total percentage of melanotic 
spleens observed at a particular time point. CYP, cyclophosphamide (i.p. 120 mg/kg 
body weight on day 9 p.d.). *0.05 > p ≥ 0.01, **0.01 > p ≥ 0.001.
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cytes and keratinocytes in the form of apoptotic bodies 
easy to phagocyte and partially degrade (Tobin, 1998). 
CYP causes massive apoptosis of various cells and depo-
sition of melanin in the form of amorphous agglomer-
ates, which are probably difficult to be absorbed (Paus et 
al., 1994a; Hendrix et al., 2005). Moreover, the popula-
tion of phagocytic cells (Quéméneur et al., 2003; Hirsch 
et al., 2004; Meinhardt et al., 2011) including splenocytes 
(Teryukova et al., 2011) may be transiently decreased and 
their capacity of devouring melanin – transiently limited. 
This means that the “naked”, toxic melanin remains in 
the CYP-treated skin (see Fig. 5D–F), where it may add 
to the bad condition of skin and, consequently, of the 
whole organism (Chuong et al., 2002; Tobin, 2006). CYP 
may also negatively influence the spleen itself, which, be-
sides poorer melanosis, may be manifested by e.g. a smaller 
size of the organ (Fig. 2C, D; Teryukova et al., 2011).
The second important conclusion concerns the sys-
temic effects of the hair cycle: catagen, both normal 
and dystrophic, is always associated with a drop in the 
splenic melanosis. Whatever mechanism stands behind 
this phenomenon, catagen in the depilation-induced hair 
cycle causes systemic effects. Therefore, regulation of 
this phase is probably dependent on factors affecting the 
whole organism.
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